Terumo and Xenex Disinfection Services announced that Terumo is the exclusive distributor of Xenex LightStrike germ-zapping robots in Japan.
Healthcare Associated Infections (HAIs) caused by pathogens such as Clostridium difficile (C.diff), Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) are a global problem, and the Xenex pulsed xenon ultraviolet (UV) room disinfection technology is a proven solution that destroys these deadly microorganisms before they can pose a threat to patients and healthcare workers.
The Xenex Germ-Zapping Robot has been proven effective against the Ebola virus and Anthrax, and can easily be incorporated into a facility’s disease containment and biodefense strategy.
“We have carefully analyzed the room disinfection industry and evaluated the various technologies that are being used to combat HAIs. In Xenex, we found an environmentally-friendly and evidence-based UV technology that has been shown to reduce hospital infection rates in multiple peer-reviewed published outcome studies, and this is why we have partnered with Xenex,” said Tsuyoshi Tomita, Division President, General Hospital Products Division, General Hospital Company at Terumo Corporation.
“We are dedicated to combatting infections, as evidenced by being the first company to launch disposable syringes in Japan. Helping hospitals bring down their infection rates is our goal, and we are confident that the Xenex LightStrike system will enable hospitals in Japan to reach this goal.”
Studies show that less than half of the surfaces in a room are disinfected properly in between patients. Xenex robots help hospitals reduce the risk of infection by destroying the microscopic germs that may be missed during the manual cleaning process.
Xenex’s germ fighting robots take room decontamination to the next level by using pulsed xenon, an environmentally-friendly noble gas, to create full spectrum, high intensity UV light that quickly destroys infectious germs.
The robot destroys C.diff spores, MRSA and other microorganisms in less than five minutes. Hospitals using Xenex devices have published outcome studies in peer-reviewed journals showing 50-100 percent decreases in C.diff, MRSA and Surgical Site Infection rates when those hospitals used the Xenex robots to disinfect rooms.
“Like Xenex, Terumo was founded by scientists and has been a leader in helping hospitals reduce their infection rates for many years. They share our passion for patient safety, and we are very proud to partner with them to provide our LightStrike Germ-Zapping Robot technology to hospitals in Japan,” said Joseph Authement , Senior Vice President of Global Sales at Xenex.
The Xenex LightStrike Germ-Zapping Robot is designed for speed, effectiveness and ease of use, which allows hospital cleaning staff to operate the robot without disrupting hospital operations.
With a four- or five-minute disinfection cycle (depending on robot model), the robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas.
More than 400 hospitals, Veterans Affairs, Department of Defense, skilled nursing, ambulatory surgery centers and long-term acute care facilities in the U.S., Africa, Canada and Europe use Xenex robots for room disinfection.